12 results for author:"Dumoulin M." in Literature citations
Results Customize
› Repeat search in UniProtKB (3)
| Disease-related amyloidogenic variants of human lysozyme trigger the unfolded protein response and disturb eye development in Drosophila melanogaster. Kumita J.R., Helmfors L., Williams J., Luheshi L.M., Menzer L., Dumoulin M., Lomas D.A., Crowther D.C., Dobson C.M., Brorsson A.C. FASEB J. 26:192-202(2012) · Mapped (5) |
| Structure and properties of a complex of alpha-synuclein and a single-domain camelid antibody. De Genst E.J., Guilliams T., Wellens J., O'Day E.M., Waudby C.A., Meehan S., Dumoulin M., Hsu S.T., Cremades N., Verschueren K.H. et al. J. Mol. Biol. 402:326-343(2010) · Mapped (1) |
| Cellular oligomerization of alpha-synuclein is determined by the interaction of oxidized catechols with a C-terminal sequence. Mazzulli J.R., Armakola M., Dumoulin M., Parastatidis I., Ischiropoulos H. J. Biol. Chem. 282:31621-31630(2007) · Mapped (7) |
| The extracellular chaperone clusterin potently inhibits human lysozyme amyloid formation by interacting with prefibrillar species. Kumita J.R., Poon S., Caddy G.L., Hagan C.L., Dumoulin M., Yerbury J.J., Stewart E.M., Robinson C.V., Wilson M.R., Dobson C.M. J. Mol. Biol. 369:157-167(2007) · UniProtKB (1) · Mapped (6) |
| Impact of the native-state stability of human lysozyme variants on protein secretion by Pichia pastoris. Kumita J.R., Johnson R.J., Alcocer M.J., Dumoulin M., Holmqvist F., McCammon M.G., Robinson C.V., Archer D.B., Dobson C.M. FEBS J. 273:711-720(2006) · Mapped (2) |
| Rationalising lysozyme amyloidosis: insights from the structure and solution dynamics of T70N lysozyme. Johnson R.J., Christodoulou J., Dumoulin M., Caddy G.L., Alcocer M.J., Murtagh G.J., Kumita J.R., Larsson G., Robinson C.V., Archer D.B. et al. J. Mol. Biol. 352:823-836(2005) · Mapped (2) |
| Identification of a universal VHH framework to graft non-canonical antigen-binding loops of camel single-domain antibodies. Saerens D., Pellis M., Loris R., Pardon E., Dumoulin M., Matagne A., Wyns L., Muyldermans S., Conrath K. J. Mol. Biol. 352:597-607(2005) · Mapped (1) |
| Reduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutations. Dumoulin M., Canet D., Last A.M., Pardon E., Archer D.B., Muyldermans S., Wyns L., Matagne A., Robinson C.V., Redfield C. et al. J. Mol. Biol. 346:773-788(2005) · Mapped (2) |
| A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme. Dumoulin M., Last A.M., Desmyter A., Decanniere K., Canet D., Larsson G., Spencer A., Archer D.B., Sasse J., Muyldermans S. et al. Nature 424:783-788(2003) · Mapped (1) |
| The disulphide mapping, folding and characterisation of recombinant Ber e 1, an allergenic protein, and SFA8, two sulphur-rich 2S plant albumins. Alcocer M.J., Murtagh G.J., Bailey K., Dumoulin M., Meseguer A.S., Parker M.J., Archer D.B. J. Mol. Biol. 324:165-175(2002) · UniProtKB (1) |
| Neurofibromatosis type I gene mutation in a patient with features of LEOPARD syndrome. Wu R., Legius E., Robberecht W., Dumoulin M., Cassiman J.-J., Fryns J.-P. Hum. Mutat. 8:51-56(1996) · UniProtKB (1) |
| Transformation and rescue of a flightless Drosophila tropomyosin mutant. Tansey T., Mikus M.D., Dumoulin M., Storti R.V. EMBO J. 6:1375-1385(1987) · Mapped (8) |